Monsenso AS (OCSE:MONSO) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:MONSO Monsenso AS OCSE:MONSO
27 GF Score
Price kr0.35
GF Value kr0.15
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Monsenso AS Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Monsenso AS is: High Risk: High uncertainty with risk-return tradeoff.

Monsenso AS  (OCSE:MONSO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Monsenso AS Risk Assessment Related Terms

OCSE:MONSO vs VEEV, BTSG, TEM: Risk Assessment Comparison

For the Health Information Services subindustry, Monsenso AS's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monsenso AS Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Monsenso AS's Risk Assessment falls into.


OCSE:MONSO
27GF Score
Monsenso AS OCSE:MONSO
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Monsenso AS (OCSE:MONSO) Overvalued in 2026?

Based on GuruFocus' analysis, Monsenso AS stock appears to be overvalued. The current stock price of kr0.35 is trading 132% above its estimated GF Value™ of kr0.15. GuruFocus considers Monsenso AS to be Significantly Overvalued.

Key valuation signals for OCSE:MONSO:

  • Risk Assessment:
  • GF Value™: kr0.15 vs. price of kr0.35 (132% above fair value)
  • GF Score™: 27/100 with 8 warning signs

No single metric tells the full story. See the OCSE:MONSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monsenso AS Business Description

Address Rosenorns Alle 31, 2, Frederiksberg, DNK, DK-1970
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. The company's mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data, and the solution helps optimise the treatment and gives a detailed overview of an individual's health through the collection of outcome, adherence, and behavioral data.
27GF Score

Get the complete analysis for OCSE:MONSO

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.35
Price
kr0.15
GF Value